Rapid IHC Edge Novodiax offers ihcDirect rapid immunohistochemistry assays delivering IVD-ready results in about 10 minutes, enabling faster diagnostic workflows and potential upsell to labs seeking quick turnaround times and increased throughput.

FFPE Workflow Benefits The ability to reduce FFPE assay time by 40-60 minutes positions Novodiax as a solution to improve pathology lab efficiency, suggesting opportunities with institutions handling FFPE tissue samples seeking faster turnaround and labor savings.

Room Temperature Simplicity Assays operate at room temperature with minimal lab space and no specialized equipment, making them attractive to smaller labs, contract research organizations, and hospital cores looking to modernize without significant capital investment.

Product Suite Expansion Beyond ihcDirect, the ihcPrime and Q-Stain products, along with custom services, offer cross-sell and partner opportunities for companion diagnostics development, research collaborations, and tiered service offerings.

Growing Market Presence With ongoing product launches since 2018 and a focus on IVD rapid tests such as CK19, CK20, CD20, and Vimentin, there is potential for targeted outreach to academic centers, biotech CROs, and diagnostic manufacturers looking to diversify rapid IHC capabilities.